PGY2 Oncology Pharmacy Residency: Memorial Cancer Institute

The Memorial Cancer Institute's (MCI) PGY2 Oncology Pharmacy Residency Program builds on the Doctor of Pharmacy education and PGY1 pharmacy residency experience to contribute to the development of oncology clinical pharmacists in advanced or specialized practice. The MCI PGY2 residency will provide the resident(s) with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy.

The program's aim is, upon successful completion of the PGY2 Oncology Pharmacy Residency, the resident will possess the competencies that qualify them for Hematology/Oncology clinical pharmacy specialist and/or faculty positions and position them to be eligible for attainment of Board Certification in Oncology Pharmacy (BCOP).

The PGY2 Oncology Pharmacy Residency Program is accredited by the American Society of Health System Pharmacists (ASHP). Throughout the year, the resident will also interact with the 15 Hematology/Oncology Fellows at MCI. Our residents are integrated into the pharmacy and healthcare team and build upon their didactic and practical experiences to develop expert knowledge in clinical patient care, medication use systems, and administrative areas of pharmacy practice.

Positions available:

2 positions (NMS Code 725660)

Outcomes

• Provide clinical and economic outcome analyses for the pharmacologic management of cancer patients.
• Optimize the outcomes of the care of individuals with cancer by providing evidence-based, patient-centered medication therapy as an integral part of an interdisciplinary team.

Moffitt Cancer Center Partnership

In 2017, MCI launched a transformative partnership for Malignant Hematology and Cellular Therapy with Moffitt Cancer Center, an NCI-designated comprehensive cancer center and NCCN member institution. In 2021, this partnership expanded to include Precision Medicine.

Educational Experience

Core Experiences

• Orientation / Oncology Pharmacy Operations
• Acute Care – Medical Oncology
• Ambulatory Care – Medical Oncology
• Acute Care – Malignant Hematology
• Ambulatory Care – Malignant Hematology and Cellular Therapy
• Investigational Drug Services
• Pediatric Hematology/Oncology
• Ambulatory Care – Breast/GYN/GU

Elective Experiences

• Advanced Compounded Sterile Preparations
• Advanced Malignant Hematology
• Advanced Cellular Therapy
• Specialty Pharmacy
• Infectious Diseases
• Integrative Medicine
• Oncology Clinical Administration
• Oncology Informatics
• Additional elective opportunities available based on resident interest

Longitudinal Experiences

• Ambulatory Care – Oral Chemotherapy Clinic (6 months)
• Ambulatory Care – Outpatient Infusion (6 months)
• Teaching and Presentations
  • 3 Required CE presentations
• Research Project
• Medication Safety and Quality
• Leadership and Formulary Management
• Oncology Clinical Operations (Staffing) - Every 3 weeks

Program Preceptors

The Oncology Pharmacy PGY2 Program Preceptors are a diverse group of dedicated oncology clinicians with experience in oncology pharmacy practice ranging from one year to 30 years. More than 70% of the PGY2 program preceptors are Board Certified in as least one area specialty area and more than half completed PGY2 training. They have all met the ASHP oncology pharmacy program preceptor eligibility criteria or are preceptors in training. In addition to the PGY2 core preceptors, the resident will work with and/or be mentored by Memorial Healthcare System's other oncology trained pharmacist in a variety of different settings.

Benefits

• Estimated Stipend: $56,500
• Health, dental, vision, disability, and life insurance
• Paid leave for holidays, vacation, sick, and bereavement leave
• Discounted meals
• Free parking
• Professional travel time and reimbursement: ASHP Midyear and HOPA Annual Meeting
• 2 flex days per rotation of dedication research time

Application Requirements

• Doctor of Pharmacy degree from ACPE-accredited school of pharmacy
• Certificate of completion from PGY1 residency program prior to start
• Florida licensure obtained within 60 days
• Official college transcript
• Curriculum vitae
• Letter of intent
• Three letters of recommendation (one from PGY1 director)
• On-site interview
• Application Deadline: January 5th

Contact Us

Frank Gentile, PharmD, BCOP

PGY2 Oncology Pharmacy Residency Program Director
fgentile@mhs.net
347-804-9521